Cat# : THP-0325
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| THP-0325 | BNT162a1 SARS-CoV-2 Vaccine | December 22, 2024 | 1 vial | $2,998.00 |
|
| Add to Cart Online Order Request a Bulk Order | |||||
| Cat#: | THP-0325 |
| Product Name: | BNT162a1 SARS-CoV-2 Vaccine |
| Description: | BNT162a1 is one of four advanced mRNA-based vaccines being developed through \"Project Lightspeed,\" a joint program between Pfizer and BioNTech. BNT162a1 is a uridine mRNA (uRNA) vaccine formulated in lipid nanoparticles for delivery via intramuscular injection.BNT162a1 is undergoing evaluation in clinical trials in both the USA (NCT04368728) and Germany (NCT04380701). |
| Species: | SARS-CoV-2 |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.
